These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7038462)

  • 21. Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.
    Iwamoto Y; Ferguson LR; Pearson A; Baguley BC
    Mutat Res; 1992 Jul; 268(1):35-41. PubMed ID: 1378184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of petite induction in yeast by acridines, ethidium and their photoaffinity probes.
    Fukunaga M; Yielding LW; Firth WJ; Yielding KL
    Mutat Res; 1981 Jun; 82(1):87-93. PubMed ID: 7022173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of petite mutants in yeast Saccharomyces cerevisiae by the anticancer drug dequalinium.
    Schneider-Berlin KR; Bonilla TD; Rowe TC
    Mutat Res; 2005 May; 572(1-2):84-97. PubMed ID: 15790492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamide.
    Rewcastle GW; Atwell GJ; Chambers D; Baguley BC; Denny WA
    J Med Chem; 1986 Apr; 29(4):472-7. PubMed ID: 3959026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of the cytoplasmic 'petite' mutation by chemical and physical agents in Saccharomyces cerevisiae.
    Ferguson LR; von Borstel RC
    Mutat Res; 1992 Jan; 265(1):103-48. PubMed ID: 1370239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The possible role of electron-transfer complexes in the antitumour action of amsacrine analogues.
    Baguley BC
    Biophys Chem; 1990 Apr; 35(2-3):203-12. PubMed ID: 2204443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents.
    Denny WA; Cain BF; Atwell GJ; Hansch C; Panthananickal A; Leo A
    J Med Chem; 1982 Mar; 25(3):276-315. PubMed ID: 7069706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide analogues.
    Baguley BC; Denny WA; Atwell GJ; Cain BF
    J Med Chem; 1981 May; 24(5):520-5. PubMed ID: 6894620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of pyrido-amsacrine analogues and related compounds.
    Llama E; Del Campo C; Capo M; Anadon M
    J Pharm Sci; 1993 Mar; 82(3):262-5. PubMed ID: 8450419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of "petite" mutants of yeast, Saccharomyces cerevisiae, by photodynamic action of acriflavine.
    Iwamoto Y; Mifuchi I
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2759-65. PubMed ID: 6388885
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: comparison of microbial and mammalian systems.
    Ferguson LR; van Zijl P; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):255-61. PubMed ID: 2649376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dose and time on the induction of genetic alterations in Saccharomyces cerevisiae by aminoacridines in the presence and absence of visible light irradiation in comparison with the dose-effect-curves of mutagens with other type of action.
    Fahrig R
    Mol Gen Genet; 1976 Mar; 144(2):131-40. PubMed ID: 775287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cytoplasmically inherited respiration-deficient ('petite') mutants by photodynamic action of acridine compounds.
    Iwamoto Y; Mifuchi I; Yielding LW; Firth WJ; Yielding KL
    Mutat Res; 1984 Feb; 125(2):213-9. PubMed ID: 6366532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-mutagenic effects of propidium on petite induction by ethidium in Saccharomyces cerevisiae.
    Fukunaga M; Yielding KL
    Mutat Res; 1980 Jan; 69(1):43-50. PubMed ID: 6987498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential antitumor agents. 47. 3'-Methylamino analogues of amsacrine with in vivo solid tumor activity.
    Atwell GJ; Baguley BC; Finlay GJ; Rewcastle GW; Denny WA
    J Med Chem; 1986 Sep; 29(9):1769-76. PubMed ID: 3755758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of petite mutations during germination and outgrowth of Saccharomyces cerevisiae ascospores.
    Redshaw RA
    J Bacteriol; 1975 Dec; 124(3):1411-6. PubMed ID: 53231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-automated structure evaluation of antileukemic 9-anilinoacridines.
    Klopman G; Macina OT
    Mol Pharmacol; 1987 Apr; 31(4):457-76. PubMed ID: 3574291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steric constraints for DNA binding and biological activity in the amsacrine series.
    Denny WA; Twigden SJ; Baguley BC
    Anticancer Drug Des; 1986 Apr; 1(2):125-32. PubMed ID: 3450288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the induction of chromosome damage and cytotoxicity for amsacrine and congeners.
    Ferguson LR; Baguley BC
    Cancer Treat Rep; 1984 Apr; 68(4):625-30. PubMed ID: 6546899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological activity and DNA interaction of anilinoacridine and bithiazole peptide derivatives related to the anti-tumor drugs m-AMSA and bleomycin.
    Morier-Teissier E; Bailly C; Bernier JL; Houssin R; Helbecque N; Catteau JP; Colson P; Houssier C; Hénichart JP
    Anticancer Drug Des; 1989 Jun; 4(1):37-52. PubMed ID: 2474298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.